Article
Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia - 1 May 2013
Witoonpanich Rawiphan, Dejthevaporn Charungthai, Pulkes Teeratorn, Tunlayadechanont Supoch, Boonkongchuen Pairoj, Pongpakdee Sunsanee, Vincent Angela
Abstract excerpt
A small but variable subgroup of patients with myasthenia gravis (MG) who have antibodies to muscle-specific kinase (MuSKAb-MG) can present with distinct phenotypes and are often treatment-resistant. The prevalence, clinical phenotypes and outcomes of treatment of patients with MuSKAb-MG in Thailand were determined. Eight (16.3%) of the 49 patients with generalized MG who were negative for acetylcholine receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.